Richard Saitz, MD, MPH, FACP, DFASAM
Professor
Boston University School of Public Health
Dept of Community Health Sciences

MD, Boston University School of Medicine
MPH, Harvard University



Richard Saitz MD, MPH, FACP (Fellow, American College of Physicians), DFASAM (Distinguished Fellow, American Society of Addiction Medicine), is a general internist (diplomate of the American Board of Internal Medicine, DABIM) and primary care physician, an addiction medicine specialist (diplomate of the American Board of Addiction Medicine, DABAM), Chair and Professor of Community Health Sciences at Boston University (BU) School of Public Health, and Professor of Medicine at BU School of Medicine. He Chaired the Treatment and Services review committee for the National Institute on Alcohol Abuse and Alcoholism, is former Editor of Evidence-Based Medicine, associate editor of JAMA, and Senior Editor of Journal of Addiction Medicine, Section Editor and sole author of key chapters in UpToDate on unhealthy substance use, an editor of the ASAM Principles of Addiction Medicine textbook, Editor Emeritus of Addiction Science & Clinical Practice, and author of over two hundred peer-reviewed publications.

He was Director of Boston Medical Center’s Clinical Addiction Research and Education (CARE) Unit for over a decade, has been Chairman of an Institutional Review Board, Associate Director of Clinical Research for BU, President of the Association for Medical Education and Research in Substance Abuse (AMERSA), steering committee member of the Motivational Interviewing Network of Trainers (MINT), and is coordinating committee member of International Network for Brief Intervention for Alcohol and other drug problems (INEBRIA). He is on the International Society of Addiction Journal Editors (ISAJE) Board now as Vice President. His primary areas of expertise supported by NIH, RWJF, and SAMHSA, are screening and brief intervention, integrating substance-related and general health care, improving the quality of care for people with unhealthy substance use, particularly in general health settings, and basing care on science. He validated single-item screening questions recommended by NIDA and NIAAA. Awards: Alpha Omega Alpha Honor Society, Boston Jaycees Ten Outstanding Young Leaders Award, Best Doctors in America®, AMERSA’s W. Anderson Spickard, Jr. Excellence in Mentorship Award, the R. Brinkley Smithers Distinguished Scientist Award (ASAM), Research Society on Alcoholism Distinguished Researcher Award.

Chair
Boston University School of Public Health
Community Health Sciences


Professor
Boston University School of Medicine
Medicine
General Internal Medicine

Active Staff Privileges
Boston Medical Center
Medicine



2017 Society of General Internal Medicine: Quality and Practice Innovation Award
2016 American Society of Addiction Medicine: Distinguished Fellow
2015 Society of General Internal Medicine: Best Published Research Paper of the Year
2012 Research Society on Alcoholism: Distinguished Researcher
2012 American Society of Addiction Medicine : R. Brinkley Smithers Distinguished Scientist
2011 Association for Medical Education and Research in Substance Abuse: W. Anderson Spickard, Jr. Excellence in Mentorship
2007 Boston University: Commencement Speaker, Seven-Year Liberal Arts/Medical Education Program (BA/MD)
2004 American Society of Addiction Medicine: Fellow
2003-2013 Best Doctors in America®
2003 Association for Medical Education and Research in Substance Abuse: Best abstract
2003 Boston Jaycees: Ten Outstanding Young Leaders
2001 Association for Medical Education and Research in Substance Abuse: Best Abstract
1999 American College of Physicans: Fellow
1997 Association for Medical Education and Research in Substance Abuse: Best Abstract
1995 Association for Medical Education and Research in Substance Abuse: New Investigator
1987 Alpha Omega Alpha Honor Society


URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F Study)
09/01/2016 - 08/31/2021 (PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
2U01AA020784-06

Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism
09/25/2014 - 08/31/2019 (PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
5R01AA021335-03

Institutional Program Unifying Population and Laboratory Based Sciences Award
02/01/2013 - 01/31/2019 (Co-PI)
PI: Lindsay Farrer, PhD
Burroughs Wellcome Fund


A Simple Large Trial of Patient-Centered Care for Opioid Use Disorders in Federally Qualified Healthcare Centers and Specialty Care Settings
09/01/2017 - 08/31/2018 (PI)
Treatment Research Institute Patient-Cnt.Out. Res

The National Drug Abuse Treatment Clinical Trials Network
09/01/2015 - 05/31/2018 (PI)
McLean Hospital Corporation NIH NIDA
5UG1DA015831-15

Clinical Addiction Research and Education (CARE) Program
05/01/2017 - 04/30/2018 (PI)
Boston Medical Center Corporation NIH NIDA
2R25DA013582-16

Relational Agent to Improve Alcohol Screening and Treatment in Primary Care
12/01/2016 - 01/31/2018 (PI)
VA Boston Healthcare System Department of VA


Personnel Agreement for Research Service of Richard Saitz
08/01/2014 - 09/14/2015 (PI)
VA Boston Healthcare System


Center to Prevent Alcohol Problems Among Young People
02/01/2004 - 01/31/2010 (Co-PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
3 P60 AA13759 05S1

Net Lifetime Health Effects of Alcohol Use and Abuse
05/16/2003 - 04/30/2008 (Co-PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
5 R01 AA13304 03

Showing 10 of 12 results. Show All Results

SBIRT for Substance Abuse in Mental Health Treatment Settings
09/15/2012 - 08/31/2017 (PI)
Univ of California, Los Angeles NIH-NIDA

Addressing Alcohol/HIV Consequences in Substance Dependence-Boston ARCH Cohort (Supplement)
03/05/2015 - 08/31/2016 (PI)
NIH-NIAAA
5U01AA020784-05

Addressing Alcohol /HIV Consequences in Substance Dependence - Boston ARCH Cohort
09/20/2011 - 08/31/2016 (PI)
NIH-NIAAA
5U01 AA020784-05

Efficacy/Effectiveness of Unhealthy Drug Use Screening
05/01/2012 - 04/30/2015 (PI)
NIH-NIDA
3R01 DA025068-05S1

Efficacy/Effectiveness of unhealthy drug use screening/Brief intervention models
07/01/2009 - 04/30/2015 (PI)
NIH-NIDA
3R01 DA025068-02S1

Efficacy/Effectiveness of Unhealthy Drug Use Screening/Brief Intervention Models
07/15/2008 - 04/30/2015 (PI)
NIH-NIDA
5R01 DA025068-05

Screening and Brief Intervention (SBI) Implementation and Sustainability
04/01/2011 - 12/31/2012 (PI)
NIH-NIDA
1R13 DA031540-01

Validation for Self-administered Single-item Screening Questions (SISQ) for Drug Use
04/01/2012 - 09/30/2012 (PI)
MITRE Corporation HRSA-SAMHSA

Alcohol SBI Research Conference
12/10/2010 - 11/30/2011 (PI)
NIH-NIAAA
1R13 AA020158-01

Linkage of Alcohol Abusers to Primary Care - Supplement
06/29/2006 - 08/31/2011 (PI)
NIH-NIAAA
3 R01 AA010870-06A2S1

Showing 10 of 14 results. Show All Results


Yr Title Project-Sub Proj Pubs
2017 Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism 5R01AA021335-04 1
2017 URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study) 5U01AA020784-07 2
2016 Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism 5R01AA021335-03 1
2016 URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study) 2U01AA020784-06 2
2015 Addressing Alcohol/HIV Consequences in Substance Dependence-Boston ARCH Cohort 3U01AA020784-04S1 2
2015 Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism 5R01AA021335-02 1
2015 Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort 5U01AA020784-05 2
2014 Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism 1R01AA021335-01A1 1
2014 Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort 5U01AA020784-04 2
2013 Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort 5U01AA020784-03 2
Showing 10 of 41 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Hodgkin D, Gao W, Merrick EL, Drebing CE, Larson MJ, Horgan CM, Sharma M, Petry NM, Saitz R. Implementing single-item screening for drug use in a Veterans Health Administration outpatient setting. Subst Abus. 2018 Mar 29; 1-32.View Related Profiles. PMID: 29595402.
     
  2. Saitz R. Absence of a quick fix does not mean 'do nothing:' time to address drug use in the ED. Emerg Med J. 2018 05; 35(5):280-281. PMID: 29599111.
     
  3. Hettema JE, Cockrell SA, Reeves A, Ingersoll KS, Lum PJ, Saitz R, Murray-Krezan CM, Carrejo VA. Development and differentiability of three brief interventions for risky alcohol use that include varying doses of motivational interviewing. Addict Sci Clin Pract. 2018 Feb 27; 13(1):6. PMID: 29482632.
     
  4. Johnson NA, Kypri K, Latter J, Dunlop A, Brown A, Saitz R, Saunders JB, Attia J, Wolfenden L, Doran C, McCambridge J. Effect of electronic brief intervention on uptake of specialty treatment in hospital outpatients with likely alcohol dependence: Pilot randomized trial and qualitative interviews. Drug Alcohol Depend. 2018 Feb 01; 183:253-260. PMID: 29306817.
     
  5. Bertholet N, Cheng DM, Palfai TP, Lloyd-Travaglini C, Samet JH, Saitz R. Anxiety, Depression, and Pain Symptoms: Associations With the Course of Marijuana Use and Drug Use Consequences Among Urban Primary Care Patients. J Addict Med. 2018 Jan/Feb; 12(1):45-52.View Related Profiles. PMID: 28984682.
     
  6. Lorkiewicz SA, Ventura AS, Heeren TC, Winter MR, Walley AY, Sullivan M, Samet JH, Saitz R. Lifetime marijuana and alcohol use, and cognitive dysfunction in people with human immunodeficiency virus infection. Subst Abus. 2018 Jan 02; 39(1):116-123.View Related Profiles. PMID: 29058572.
     
  7. Bagley SM, Hadland SE, Carney BL, Saitz R. Addressing Stigma in Medication Treatment of Adolescents With Opioid Use Disorder. J Addict Med. 2017 Nov/Dec; 11(6):415-416.View Related Profiles. PMID: 28767537.
     
  8. Kim TW, Walley AY, Ventura AS, Patts GJ, Heeren TC, Lerner GB, Mauricio N, Saitz R. Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence. AIDS Care. 2018 Feb; 30(2):150-159.View Related Profiles. PMID: 29034725.
     
  9. Chavez KE, Palfai TP, Squires LE, Cheng DM, Lloyd-Travaglini C, Saitz R. Perceived discrimination and drug involvement among black primary care patients who use drugs. Addict Behav. 2018 Feb; 77:63-66.View Related Profiles. PMID: 28965068.
     
  10. Kim TW, Walley AY, Heeren TC, Patts GJ, Ventura AS, Lerner GB, Mauricio N, Saitz R. Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence. J Subst Abuse Treat. 2017 Oct; 81:1-10.View Related Profiles. PMID: 28847449.
     
Showing 10 of 255 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 255 publications over 26 distinct years, with a maximum of 24 publications in 2007

YearPublications
19911
19921
19942
19953
19973
19983
19996
20005
20015
20024
20036
20046
20058
200611
200724
200812
20098
201020
20117
201216
201317
201423
201518
201620
201721
20185

Professor Saitz mentors trainees at all levels in research, mainly masters, doctoral students, and junior faculty, and is career mentor when appropriate as well.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Saitz's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department